Vaccine-preventable childhood diseases in Australia
Too much disease, not enough vaccination: what more can we do?
MJA 1996; 164: 61
Readers may print a single copy for personal use. No further reproduction or distribution of the articles should proceed without the permission of the publisher. For permission, contact the Australasian Medical Publishing Company
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au/>".
-
©MJA1997
Why do we still have so much disease despite good vaccines and good
delivery systems?
While there is a lack of uniform reliable data on vaccination
coverage, it would seem our national childhood vaccination rates are
inadequate. The Australian Bureau of Statistics' 1989-90 National
Health Survey reported that, according to parental recall, 53% of
children up to six years of age had been vaccinated in accord with the
National Health and Medical Research Council (NHMRC) vaccination
schedules.2 Unpublished
data from State health departments include the report of a 1991
cluster survey in Victoria of 630 children aged 18 months to 3 years
which found that 88% were fully vaccinated against diphtheria,
pertussis, tetanus, polio and measles (John Carnie, Manager,
Infectious Diseases Unit, Victorian Department of Health and
Community Services, Melbourne, personal communication); a 1994 ACT
report found that only 67% of 236 children at school entry (aged about
five years) were fully vaccinated (Ms Ann Kempe, Immunisation
Coordinator, ACT Department of Health and Community Care, Canberra,
personal communication).
Whatever the true vaccination coverage, continuing notifications
(in the thousands) of cases of measles, with its well-known risks of
encephalitis, bronchopneumonia and subacute sclerosing
panencephalitis (SSPE), highlight how much still needs to be done. In
the United Kingdom a recent national measles-rubella immunisation
program has successfully terminated measles virus circulation in
schools; in March and April 1995, there were four confirmed cases of
measles in England and Wales; three cases had recently arrived in the
country, and the other occurred in an unvaccinated 15-month-old
child.3 In Australia there
were 229 measles notifications for the same period (National
Notifiable Diseases Surveillance System, personal
communication).
The National Childhood Immunisation Committee has implemented a
number of initiatives over the past two years to increase vaccination
coverage rates in line with the goals of the 1993 NHMRC National
Childhood Immunisation Strategy.4
More than 30 000 copies of a kit, which included the fifth
edition of the Australian immunisation procedures handbook,5 were distributed to
general practitioners and other vaccination service providers. A
parents' guide to immunisation, Understanding childhood
immunisation,6 was also
produced and widely distributed; a recent mass media awareness
campaign offers this booklet free to enquirers through a toll-free
telephone number (1800 671 811). Such initiatives have received
broad professional and community support from organisations such as
the Australian Medical Assocation, the Royal Australian College of
General Practitioners, the Australian College of Paediatrics, the
Australian Institute of Environmental Health, the Sudden Infant
Death Association and the NHMRC.
The safety and efficacy of vaccines are apparent to all but a few. A
scheme to record, follow-up and regularly publish significant
adverse events following vaccination has been under way since March
1995 (general practitioners and other providers notifying
respective State or Territory health authorities by telephone). The
data are collated, reviewed and published monthly in
Communicable Diseases Intelligence. Adverse event rates of
less than 1% have been recorded, although the data are as yet
incomplete.
Nevertheless, there is still a lack of awareness on the part of parents
and even some health practitioners of the benefit-risk equation for
vaccination, at least for some vaccines. A few individuals who
propagate tired myths of exaggerated vaccination harm, however
sincerely, make it more difficult to provide concerned parents with
balanced benefit-risk information.
To address this problem Commonwealth funding of $24 million has been
allocated towards childhood vaccination during 1995-96 and
1996-97. Most of this outlay is provided to the States and Territories
to purchase NHMRC standard childhood immunisation schedule
vaccines in return for their undertaking to provide a coordinated
program. Some of this funding will be used to obtain better
information about vaccination coverage via the Australian
Childhood Immunisation Register, which commenced on 1 January 1996.
Information from the Register will enable resources to be targeted
effectively to assist areas with the lowest coverage rates.
Combination 4-in-1 (tetravalent) and 5-in-1 (pentavalent)
vaccines (e.g., against diphtheria, tetanus, polio,
Haemophilus influenzae type b and hepatitis B), less
reactogenic acellular pertussis vaccines, as well as a varicella
vaccine, are soon to appear on local markets. On the eve of the third
millennium, once again we as a nation will need to debate the
cost-benefit of disease prevention. In this debate we must
acknowledge how far we have come in the two hundred years since
Jenner's successful inoculations against smallpox, and how far we
have yet to go.
Gavin W Frost
Monica Johns
©MJA 1997
<URL: http://www.mja.com.au/>
© 1997 Medical Journal of Australia.
In 1994, there were 17 442 notifications of vaccine- preventable
diseases in Australia.1 This
disgraceful situation exists despite the ready availability of
free, safe and effective vaccines. Particularly damning were the
8661 cases of pertussis, measles, mumps, rubella and Haemophilus
influenzae type b notified in children up to school leaving age
(19 years old) -- all diseases for which a national immunisation
program has been in place for many years!
there is still a lack
of awareness on the part of parents and even some health practitioners of the benefit-risk equation for vaccination
On the other hand, notifications of invasive Haemophilus
influenzae type b have decreased from at least 3.5 cases per 100
000 population in 19911 to 1
case per 100 000 in 1994.1
Within three years we may see less than a quarter the number of cases of
childhood bacterial meningitis recorded in 1990 -- evidence of the
benefit of effective vaccination.
Technical considerations also play a role in ensuring the optimal
efficacy of vaccines: guidelines and systems for cold-chain
maintenance have been implemented (some local studies have
suggested that some vaccine providers have difficulty maintaining
vaccines at between 2-81/4C7,8
); knowledge of the thermolability of reconstituted measles-mumps-
rubella vaccines and of oral polio vaccine at room temp erature is
another important consideration.
Senior Medical Adviser, AIDS/Communicable Diseases Branch
Commonwealth Department of Human Services and Health, Canberra, ACT
Senior Project Officer, National Childhood Immunisation Program
Commonwealth Department of Human Services and Health, Canberra, ACT
- Gavin W Frost
- Monica Johns